Shell Asset Management CO Blueprint Medicines Corp Transaction History

Shell Asset Management CO

$2.27 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$41.06 - $66.48 $37,077 - $60,031	-903 Reduced 16.88%	4,448 $195,000
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $70,101 - $109,090	-1,404 Reduced 20.78%	5,351 $353,000
Q2 2022 Aug 09, 2022	BUY	$45.23 - $70.15 $452 - $701	10 Added 0.15%	6,755 $341,000
Q1 2022 May 04, 2022	SELL	$54.1 - $110.08 $54,045 - $109,969	-999 Reduced 12.9%	6,745 $431,000
Q4 2021 Feb 09, 2022	BUY	$94.25 - $115.99 $2,921 - $3,595	31 Added 0.4%	7,744 $829,000
Q3 2021 Nov 04, 2021	SELL	$80.98 - $109.47 $26,723 - $36,125	-330 Reduced 4.1%	7,713 $793,000
Q2 2021 Aug 12, 2021	BUY	$82.78 - $101.0 $36,423 - $44,440	440 Added 5.79%	8,043 $707,000
Q1 2021 May 10, 2021	BUY	$90.71 - $108.28 $267,957 - $319,859	2,954 Added 63.54%	7,603 $739,000
Q4 2020 Feb 16, 2021	BUY	$92.08 - $124.48 $64,179 - $86,762	697 Added 17.64%	4,649 $521,000
Q2 2020 Aug 10, 2020	SELL	$57.09 - $79.27 $4,966 - $6,896	-87 Reduced 2.15%	3,952 $308,000
Q1 2020 May 11, 2020	SELL	$48.11 - $82.22 $2,982 - $5,097	-62 Reduced 1.51%	4,039 $236,000
Q4 2019 Feb 13, 2020	SELL	$66.73 - $82.59 $8,674 - $10,736	-130 Reduced 3.07%	4,101 $329,000
Q3 2019 Nov 12, 2019	SELL	$72.9 - $101.41 $2,697 - $3,752	-37 Reduced 0.87%	4,231 $311,000
Q2 2019 Aug 12, 2019	SELL	$73.54 - $97.8 $7,206 - $9,584	-98 Reduced 2.24%	4,268 $403,000
Q4 2018 Feb 13, 2019	SELL	$45.57 - $74.26 $18,228 - $29,704	-400 Reduced 8.39%	4,366 $235,000
Q2 2018 Aug 10, 2018	SELL	$60.96 - $101.18 $16,398 - $27,217	-269 Reduced 5.34%	4,766 $303,000
Q4 2017 Feb 09, 2018	BUY	$62.91 - $88.32 $316,751 - $444,691	5,035	5,035 $380,000

Others Institutions Holding BPMC

# of Institutions

351

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$605 Million
0.01% of portfolio
Black Rock Inc. New York, NY

6.65M
Shares

$601 Million
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

5.39M
Shares

$487 Million
0.06% of portfolio
Wellington Management Group LLP Boston, MA

3.96M
Shares

$359 Million
0.07% of portfolio
State Street Corp Boston, MA

2.77M
Shares

$250 Million
0.01% of portfolio

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account